Skip to main content
Premium Trial:

Request an Annual Quote

VA Awards Personalis Contract to Provide Clinical Exome Services

NEW YORK (GenomeWeb) – Personalis said today that the US Department of Veterans Affairs has awarded it a contract to provide clinical exome sequencing services.

The Menlo Park, Calif.-based firm will use its ACE Clinical Exome Test, which provides enhanced coverage of 8,000 genes related to disease and coverage of medically important non-coding regions, to identify the causes of patients' genetic disorders.

The VA previously awarded Personalis a contract to provide sequencing and data analysis for 1,000 individuals under its Million Veteran Program.

"This is a great validation of the Personalis difference — the value of our focus on accuracy, sophisticated analysis, and interpretation that we provide for genome and exome sequencing and analysis," Personalis CEO John West said in a statement.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.